On Wednesday, November 23, US-based medical technology company Becton Dickinson announced a new investment project in the Hungarian city of Tatabanya to increase production capacity. The investment is expected to create an additional 219 new jobs.
Speaking at a press conference in Budapest, Hungarian Foreign minister Péter Szijjártó announced that American medical technology company Becton Dickinson will expand its factory in Tatabanya with an investment totaling $11.6 million (34 billion forints). Szijjártó said that the investment in the medical supply industry, which currently employs 12,000 Hungarian workers, “shows that American capital has continued confidence in Hungary.” “Everybody is a winner with the reduction of corporation tax to a flat rate of 9%, including large companies as well as small and medium-sized enterprises, which can gain strength if they succeed in becoming part of the supply chain of a large international company producing in Hungary,” said the Foreign Minister.
Becton Dickinson Representative Csaba Vecsernyés added that the US company has spent over $250 million expanding its manufacturing and expanding production footprint in Hungary since 2007. Currently, Becton Dickinson employs 700 workers in Tatabánya. Vecsernyés said completion of the project is expected to take 3 years – Becton Dickinson is currently in the planning process and construction itself will begin in 8-10 months.
Becton Dickinson is a global medical technology company that develops, produced and distributed medical supplies, diagnostic instrument systems, and reagents. The company, established in 1897 is headquartered in New Jersey and employs some 45,000 persons in 50 countries worldwide.